Pfizer begins stage 2 and 3 trials of COVID-19 antiviral treatment on children | The Hill: Healthcare Policy

Pfizer on Wednesday announced it has begun phase 2 and 3 stages of its study into the use of its antiviral COVID-19 treatment in young children.The oral COVID-19 treatment called PAXLOVID is currently one of two authorized SARS-...